Mel-Mont Medical
Mel-Mont Medical is a molecular diagnostics company focused on preserving life through early detection and prevention of HPV-related cancers. The company develops patented and clinically proven non-invasive self-sampling devices combined with proprietary comprehensive molecular testing to improve health outcomes. Mel-Mont's team of scientists and molecular biologists develops technologies that identify active…
Funding snapshot
About
Mel-Mont Medical is a molecular diagnostics company focused on preserving life through early detection and prevention of HPV-related cancers. The company develops patented and clinically proven non-invasive self-sampling devices combined with proprietary comprehensive molecular testing to improve health outcomes. Mel-Mont's team of scientists and molecular biologists develops technologies that identify active infections of High-Risk Human Papilloma Virus at early stages. The product portfolio includes medical devices for HR-HPV cancer prevention, in vitro diagnostics through its PreTect division with an ISO 13485-certified HPV-mRNA molecular laboratory service, and sample preparation reagents for molecular testing. The company follows a rigorous six-step development process from idea creation through market launch with techno-surveillance. Founded in 2014, headquartered in Doral, United States, The company has raised $10.2M at the Series A stage..
Business model
Oncology > In-Vitro Diagnostic Tests > Women's Cancer > Cervical Cancer,
Genomics > Enabling Technologies > Kits and Reagents > Bioreagents
Team background
College Wise > University of Warwick
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.